Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric CancerJeonghun Kim, Myung‐Hee Sohn, Hwan‐Jeong Jeong et al.|Nuclear Medicine and Molecular Imaging|2013Cited by 37
The Clinical Value of Hybrid Sentinel Lymphoscintigraphy to Predict Metastatic Sentinel Lymph Nodes in Breast CancerChang Ju Na, Seok Tae Lim, Jeonghun Kim et al.|Nuclear Medicine and Molecular Imaging|2014Cited by 8
Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid CancerSehun Choi, Seok Tae Lim, Chang Ju Na et al.|Nuclear Medicine and Molecular Imaging|2014Cited by 5
A phase II clinical trial to investigate the effect of pioglitazone on 18F-FDG uptake in malignant lesionsYeon‐Hee Han, Hwan‐Jeong Jeong, Seong Young Kwon et al.|EJNMMI Research|2015Cited by 4
Valuable parameters to evaluate progression free survival on pretreatment F-18 FDG PET/CT in gastric cancerJeonghun Kim, Myung‐Hee Sohn, Seok Tae Lim et al.|Journal of Nuclear Medicine|2013Cited by 0